Dargantes, Bonifacio T.
HRN: 24-97-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/05/2024
05/12/2024
IVT
2.25g
Q6
Infected Wound, Right Foot
Waiting Final Action
Indication: Empiric Type of Infection: Disseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes